Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

SK&F 106615

Known as: SK&F-106615, Azaspirane SK&F106615, SK&F106615 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Type 1 diabetes (T1D), which resulting in hyperglycemia, is an autoimmune disease. This disease characterized by destruction of… Expand
  • table 1
Is this relevant?
1999
1999
Azaspiranes are novel macrophage-targeting agents with activity in preclinical animal models of autoimmune disease and… Expand
Is this relevant?
1999
1999
Azaspiranes are cationic amphiphilic compounds that are active in a number of models of autoimmune disease and transplantation… Expand
Is this relevant?
1998
1998
Abstract.Objective and Design: The ability of azaspiranes to modulate the acute inflammatory response in models of skin… Expand
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
1997
1997
The azaspiranes are novel immunomodulators which are effective in a variety of animal models of autoimmune disease and… Expand
Is this relevant?
1996
1996
OBJECTIVE To evaluate the effect of SK&F 106615 on joint integrity in rats with adjuvant-induced arthritis (AIA). METHODS AIA… Expand
Is this relevant?
1995
1995
 
Is this relevant?
1993
1993
The azaspirane SKF 105685 (N,N-dimethyl-8, 8-dipropyl-2-azaspiro (4.5) decane-2-propanamine dihydrochloride) has been shown to… Expand
Is this relevant?